Freedom Investment Management, Inc. - GW PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2019$667,000
-34.2%
5,801
-1.2%
0.06%
-31.8%
Q2 2019$1,013,000
-1.7%
5,874
-3.9%
0.08%
+2.4%
Q1 2019$1,030,000
+120.6%
6,110
+27.5%
0.08%
+130.6%
Q4 2018$467,000
-32.9%
4,794
-1.4%
0.04%
-18.2%
Q3 2018$696,000
+2.7%
4,861
+0.0%
0.04%
+7.3%
Q2 2018$678,000
+46.4%
4,859
+18.3%
0.04%
+70.8%
Q1 2018$463,000
-7.4%
4,109
+8.4%
0.02%
-7.7%
Q4 2017$500,000
+46.2%
3,791
+12.6%
0.03%
+36.8%
Q3 2017$342,000
+17.5%
3,367
+16.1%
0.02%
+11.8%
Q2 2017$291,000
+2.5%
2,899
+23.3%
0.02%0.0%
Q1 2017$284,0002,3520.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders